Iran University of Medical Sciences | Iran
Milad Shirvaliloo holds an MD and an MBA in Health Sciences and is an aspiring physician-researcher with over six years of investigative experience in epigenetics, cancer biology and pulmonary medicine. He has published more than 40 peer-reviewed articles and a book chapter, and serves on the Editorial Board of Epigenomics and as reviewer for 60+ Web of Science-indexed journals. His academic journey includes medical education at Tabriz University of Medical Sciences and postgraduate research at Iran University of Medical Sciences focusing on nanoparticle-based therapeutic interventions and histone acetylation in cancer. His work spans diagnostics (e.g., nano-biosensor assays for SARS-CoV-2), lung epithelium development (epigenetic cues in human lung organoids) and cancer nano-theranostics (targeted magnetochemotherapy and histone modification mapping). According to h-index is 16 and he has amassed over 819 citations to date. His main research interests include histone modifications, chromatin accessibility, nanoparticle-mediated drug delivery and epigenetic biomarkers in respiratory and oncologic diseases. He brings strong skills in scientific communication, evidence synthesis, statistical & bioinformatics analysis and R programming. In conclusion, Milad’s interdisciplinary expertise positions him at the interface of molecular epigenetics and translational nanomedicine with the aim to advance precision diagnostics and therapies.
Featured Publications
Heris, R. M., Shirvaliloo, M., Abbaspour-Aghdam, S., Hazrati, A., Shariati, A., & Youshanlouei, H. R., et al. (2022). The potential use of mesenchymal stem cells and their exosomes in Parkinson’s disease treatment. Stem Cell Research & Therapy, 13(1), 371.
Sheervalilou, R., Shirvaliloo, M., Dadashzadeh, N., Shirvalilou, S., Shahraki, O., & Pilehvar-Soltanahmadi, Y., et al. (2020). COVID‐19 under spotlight: A close look at the origin, transmission, diagnosis, and treatment of the 2019‐nCoV disease. Journal of Cellular Physiology, 235(12), 8873–8924.
Aghbash, P. S., Eslami, N., Shirvaliloo, M., & Baghi, H. B. (2021). Viral coinfections in COVID‐19. Journal of Medical Virology, 93(9), 5310–5322.
Shirvalilou, S., Khoei, S., Esfahani, A. J., Kamali, M., Shirvaliloo, M., & Sheervalilou, R., et al. (2021). Magnetic hyperthermia as an adjuvant cancer therapy in combination with radiotherapy versus radiotherapy alone for recurrent/progressive glioblastoma: A systematic review. Journal of Neuro-Oncology, 152(3), 419–428.
Razlansari, M., Jafarinejad, S., Rahdar, A., Shirvaliloo, M., Arshad, R., & Fathi-Karkan, S., et al. (2023). Development and classification of RNA aptamers for therapeutic purposes: An updated review with emphasis on cancer. Molecular and Cellular Biochemistry, 478(7), 1573–1598.